000 | 00910cam a2200265 a 4500 | ||
---|---|---|---|
001 | vtls003227521 | ||
003 | MY-SjTCS | ||
005 | 20200226110704.0 | ||
008 | 111206s2010 sz a b 001 0 eng | ||
020 | _a9783764389888 (hbk.) | ||
020 | _a3764389885 (hbk.) | ||
020 | _z9783764389895 (ebk.) | ||
039 | 9 |
_a201701181126 _bpushpa _c201203131103 _dwilmina _c201202281512 _dmalathy _y201112061407 _zmalathy |
|
082 | 0 | 4 |
_a615.7 _bEPI 2011 |
245 | 0 | 0 |
_aEpigenetics and disease : _bpharmaceutical opportunities / _cSusan M. Gasser, En Li, editors. |
260 |
_aBasel : _bSpringer, _cc2011. |
||
300 |
_ax, 270 p. : _bill. (some col.) ; _c24 cm. |
||
490 | 0 |
_aProgress in drug research ; _v67 |
|
504 | _aIncludes bibliographical references and index. | ||
650 | 0 |
_aPharmacogenetics. _920660 |
|
650 | 0 |
_aEpigenesis. _947444 |
|
700 | 1 | _aGasser, Susan M. | |
700 | 1 | _aLi, En. | |
920 | _aPHA : 177544 | ||
999 |
_c70750 _d70750 |